LARS anticorps
-
- Antigène Voir toutes LARS Anticorps
- LARS (Leucyl-tRNA Synthetase (LARS))
-
Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp LARS est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF), Immunoprecipitation (IP)
- Purification
- Immunogen affinity purified
- Pureté
- ≥95 % as determined by SDS-PAGE
- Immunogène
- leucyl-tRNA synthetase
- Isotype
- IgG
- Top Product
- Discover our top product LARS Anticorps primaire
-
-
- Indications d'application
- WB: 1:500-1:2000, IP: 1:200-1:1000, IHC: 1:20-1:200, IF: 1:20-1:200
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
- Date de péremption
- 12 months
-
- Antigène
- LARS (Leucyl-tRNA Synthetase (LARS))
- Autre désignation
- LARS (LARS Produits)
- Sujet
- Synonyms:KIAA1352 Background:Catalyzes the specific attachment of an amino acid to its cognate tRNA in a two step reaction: the amino acid(AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA. Exhibits a post-transfer editing activity to hydrolyze mischarged tRNAs.
- Poids moléculaire
- 135-140 kDa
- ID gène
- 51520
- UniProt
- Q9P2J5
- Pathways
- EGFR Signaling Pathway
-